Focusing on Task of Reinventing Peptide Drugs Unigene Has Introduced an Enzyme-Based Assay for the Discovery of Amidated Peptides Warren P.Levy, Ph.D.
Peptides are among the most biologically relevant molecules known and also among the most productive areas of pharmaceutical R&...
Focusing on Task of Reinventing Peptide Drugs Unigene Has Introduced an Enzyme-Based Assay for the Discovery of Amidated Peptides Warren P.Levy, Ph.D.
Peptides are among the most biologically relevant molecules known and also among the most productive areas of pharmaceutical R&...
Olympian, Legendary Swimmer Gary Hall Jr. Teams With Lilly to Serve as Ambassador for Inspired By Diabetes Cam 10-time medalist seeks third straight gold medal in 2008 Beijing Games When Olympian Gary Hall Jr.was diagnosed with diabetes, his physician prescribed Eli Lilly and Company's fast-acting insulin Humalog(R) (insulin lispro injection [rDNA...
Olympian, Legendary Swimmer Gary Hall Jr. Teams With Lilly to Serve as Ambassador for Inspired By Diabetes Cam When Olympian Gary Hall Jr.was diagnosed with diabetes, his physician prescribed Eli Lilly and Company's fast-acting insulin Humalog (insulin lispro injection [rDNA origin]) to help manage his blood sugar and keep alive his gold...
Olympian, Legendary Swimmer Gary Hall Jr. Teams With Lilly to Serve as Ambassador for Inspired By Diabetes Cam When Olympian Gary Hall Jr.was diagnosed with diabetes, his physician prescribed Eli Lilly and Company's fast-acting insulin Humalog(R) (insulin lispro injection [rDNA origin]) to help manage his blood sugar and keep alive his gold-medal...
Olympian, Legendary Swimmer Gary Hall Jr. Teams With Lilly to Serve as Ambassador for Inspired By Diabetes Cam When Olympian Gary Hall Jr.was diagnosed with diabetes, his physician prescribed Eli Lilly and Company's fast-acting insulin Humalog(R) (insulin lispro injection [rDNA origin]) to help manage his blood sugar and keep alive his gold-medal...
Olympian, Legendary Swimmer Gary Hall Jr. Teams With Lilly to Serve as Ambassador for Inspired By Diabetes Cam When Olympian Gary Hall Jr.was diagnosed with diabetes, his physician prescribed Eli Lilly and Company's fast-acting insulin Humalog(R) (insulin lispro injection [rDNA origin]) to help manage his blood sugar and keep alive his gold-medal...
Olympian, Legendary Swimmer Gary Hall Jr. Teams With Lilly to Serve as Ambassador for Inspired By Diabetes Cam When Olympian Gary Hall Jr.was diagnosed with diabetes, his physician prescribed Eli Lilly and Company's fast-acting insulin Humalog(R) (insulin lispro injection [rDNA origin]) to help manage his blood sugar and keep alive his gold-medal...
Olympian, Legendary Swimmer Gary Hall Jr. Teams With Lilly to Serve as Ambassador for Inspired By Diabetes Cam When Olympian Gary Hall Jr.was diagnosed with diabetes, his physician prescribed Eli Lilly and Company's fast-acting insulin Humalog(R) (insulin lispro injection [rDNA origin]) to help manage his blood sugar and keep alive his gold-medal...
Olympian, Legendary Swimmer Gary Hall Jr. Teams With Lilly to Serve as Ambassador for Inspired By Diabetes Cam When Olympian Gary Hall Jr.was diagnosed with diabetes, his physician prescribed Eli Lilly and Company's fast-acting insulin Humalog(R) (insulin lispro injection [rDNA origin]) to help manage his blood sugar and keep alive his gold-medal...
Olympian, Legendary Swimmer Gary Hall Jr. Teams With Lilly to Serve as Ambassador for Inspired By Diabetes Cam When Olympian Gary Hall Jr.was diagnosed with diabetes, his physician prescribed Eli Lilly and Company's fast-acting insulin Humalog(R) (insulin lispro injection [rDNA origin]) to help manage his blood sugar and keep alive his gold-medal...
FDA delays decision on Eli Lilly blood clot drug prasugrel by 3 months, few surprised a day after the company announced the Food and Drug Administration needed three more months to review its blood thinner drug.The FDA did not ask for new clinical trials, but company spokeswoman Tammy Hull would not go into details about...
FDA delays decision on Eli Lilly blood clot drug prasugrel by 3 months, few surprised a day after the company announced the Food and Drug Administration needed three more months to review its blood thinner drug.The FDA did not ask for new clinical trials, but company spokeswoman Tammy Hull would not go into details about...
ADA: Pramlintide May Be Better Choice than Insulin as Mealtime Diabetes Add-on Drug SAN FRANCISCO, June 12 -- For diabetic patients recently started on long-acting insulin, mealtime pramlintide (Symlin) may boost blood sugar control similar to rapid-acting insulin but with fewer side effects, researchers found.The drug...
Would You Cure A Profitable Disease? This article was originally published in Diabetes Health in October, 2003.People in the diabetes community, desperate for a cure, sometimes express considerable paranoia about the goals of the pharmaceutical industry.
After all, with ...
Amylin and Novo Nordisk Battle For GLP-1 Market Dominance (BioWorld Today Via Acquire Media NewsEdge) With few new compelling data presented at this year's American Diabetes Association Scientific Sessions annual meeting in San Francisco, Wall Street's focus turned to the expected competition in...
Amylin and Novo Nordisk Battle For GLP-1 Market Dominance With few new compelling data presented at this year's American Diabetes Association Scientific Sessions annual meeting in San Francisco, Wall Street's focus turned to the expected competition in the glucagon-like peptide-1 (GLP-1) market.
Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombina /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced new Phase I data for the company's diabetes mellitus program at...
Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombina SAN FRANCISCO, June 9 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced new Phase I data for the company's...
SAN DIEGO--- Trius Appoints Paul Truex to Board of Directors Trius Therapeutics, Inc.today announced the appointment of Paul Truex to its Board of Directors.
Truex is the founder, President and CEO of Anthera Pharmaceuticals.
Previously, he served as President and CEO of Peninsula...
Trius Appoints Paul Truex to Board of Directors Industry veteran brings business development and transaction expertise -- Trius Therapeutics, Inc.today announced the appointment of Paul Truex to its Board of Directors.
Truex is the founder, President and CEO of Anthera...
::: Trius Appoints Paul Truex to Board of Directors Industry veteran brings business development and transaction expertise SAN DIEGO, June 2 /PRNewswire/ -- Trius Therapeutics, Inc.today announced the appointment of Paul Truex to its Board of Directors.
Truex is the founder, President...
Trius Appoints Paul Truex to Board of Directors Industry veteran brings business development and transaction expertise SAN DIEGO, June 2 /PRNewswire/ -- Trius Therapeutics, Inc.today announced the appointment of Paul Truex to its Board of Directors.
Truex is the founder, President...
Trius Appoints Paul Truex to Board of Directors SAN DIEGO, June 2 /PRNewswire/ -- Trius Therapeutics, Inc.today announced the appointment of Paul Truex to its Board of Directors.
Truex is the founder, President and CEO of Anthera Pharmaceuticals.
Previously he served as President...
Trius Appoints Paul Truex to Board of Directors Trius Therapeutics, Inc.today announced the appointment of Paul Truex to its Board of Directors.
Truex is the founder, President and CEO of Anthera Pharmaceuticals.
Previously, he served as President and CEO of Peninsula...
